Home > Financial Ratios > BLISS GVS PHARMA

BLISS GVS PHARMA
Core EBITDA Growth

    Back to All Ratios
BLISS GVS PHARMA is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for BLISS GVS PHARMA
Please provide your vote to see the results

BLISS GVS PHARMA Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) -9.0232.75-9.8316.51-20.86

What is the latest Core EBITDA Growth ratio of BLISS GVS PHARMA ?

The latest Core EBITDA Growth ratio of BLISS GVS PHARMA is -9.02 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar2025-9.02
Mar202432.75
Mar2023-9.83
Mar202216.51
Mar2021-20.86

How is Core EBITDA Growth of BLISS GVS PHARMA Trending?

Years Core EBITDA Growth % Change
Mar2025 -9.02
Negative
Mar2024 32.75
Positive
Mar2023 -9.83
Negative
Mar2022 16.51
Positive
Mar2021 -20.86 -

Other Financial Ratios of BLISS GVS PHARMA


Compare Core EBITDA Growth ratio of peers of BLISS GVS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BLISS GVS PHARMA ₹1,716.0 Cr -2.4% 5.9% 20.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹384,002.0 Cr -2.1% -5.8% -6.7% Stock Analytics
DIVIS LABORATORIES ₹164,334.0 Cr 3.1% -6.5% 28.7% Stock Analytics
CIPLA ₹127,613.0 Cr 2.2% 3.2% 1.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,923.0 Cr -1.7% NA 9.6% Stock Analytics
DR REDDYS LABORATORIES ₹105,437.0 Cr 1.4% -1.1% -7.6% Stock Analytics


BLISS GVS PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BLISS GVS PHARMA

-2.4%

5.9%

20.7%

SENSEX

-1.1%

-1.7%

-0.3%


You may also like the below Video Courses